Maya Dusenbery’s book Doing Harm explores gender bias in today’s medical system.
By Dorothy Kupcha Leland
“Super responders” are key to personalized Lyme disease treatment.
By Lorraine Johnson, JD, MBA
Lyme patients all hope to find the most effective treatment with the fewest side effects.
By Lorraine Johnson, JD, MBA
Lyme disease cases for 2017 are actually much higher than the CDC-reported number—as much as 10 times higher.
By Dorothy Kupcha Leland
Canadian Lyme Patients to “Give Input” on Matters Already Decided.
By Vett Lloyd, PhD; Liz Zubek, MD, CCFP FCFP; Sue Faber and Jennifer Kravis, co-founders, LymeHope; Janet Sperling, CanLyme; Linda Kelso, Ontario Lyme Alliance
We could potentially use the data from MyLymeData.org to build a research engine.
By Lorraine Johnson, JD, MBA
Many U.S. and Canadian Lyme patients are traveling to the Lyme Mexico Clinic for alternative treatments.
By Dorothy Kupcha Leland
Most patients with late or chronic Lyme disease waited years for proper diagnosis with devastating consequences.
By Lorraine Johnson, JD, MBA
There are those who say you can’t have Lyme because it “doesn’t exist” where you live.
By Dorothy Kupcha Leland
Who decides what constitutes scientific evidence for chronic Lyme disease?
By Phyllis Mervine
Some claim that chronic Lyme disease is not a legitimate diagnosis.
By Lorraine Johnson, JD, MBA
Broader criteria are needed for chronic Lyme disease diagnosis.
By Lorraine Johnson, JD, MBA
Subscribe to our mailing list and get Lyme disease news updates to your email inbox.
We respect your privacy and take protecting it seriously.